$ZTS Cashflow Statement | Understand Stock

$ZTS

$80.97 -$0.06 (0.07%) Close

$ZTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities
Net income before allocation to noncontrolling interests
Adjustments to reconcile net income before noncontrolling interests to net cash provided by operating activities:
Depreciation and amortization expense
Share-based compensation expense
Asset write-offs and asset impairments
Net loss/(gain) on sale of businesses, excluding transaction costs
Provision for losses on inventory
Deferred taxes
Employee benefit plan contribution from Pfizer Inc.
Settlement of derivative contracts
Other non-cash adjustments
Other changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable
Inventories
Other assets
Accounts payable
Other liabilities
Other tax accounts, net
Net cash provided by operating activities
Investing Activities
Capital expenditures
Acquisitions, net of cash acquired
Purchase of investments
Net proceeds from sale of assets
Proceeds from maturities and redemptions of investments
(Payments of)/proceeds from derivative instrument activity, net
(Payment of)/proceeds from sale of businesses, net of cash sold and working capital adjustments
Other investing activities
Net cash used in investing activities

Financing Activities
(Decrease)/increase in short-term borrowings, net
Principal payments on long-term debt
Proceeds from issuance of long-term debt—senior notes, net of discount
Proceeds from issuance of convertible debt
Payment of debt issuance costs
Payment of consideration related to previous acquisitions
Share-based compensation-related proceeds, net of taxes paid on withholding shares and excess tax benefits
Share-based compensation-related proceeds, net of taxes paid on withholding shares
Cash dividends paid
Acquisition of a noncontrolling interest, net of cash acquired
Other financing activities
Net cash used in financing activities

Effect of exchange-rate changes on cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Supplemental cash flow information
Cash paid during the period for:
Income Taxes Paid, Net
Interest, net of capitalized interest
Non-cash transactions:
Capital expenditures
Contingent purchase price consideration
Dividends payable

Payments to Settle Derivative Instruments
Excise tax accrued on net share repurchases, not paid

Comments